The US nicotine market is undergoing historical changes. This should be celebrated as a major public health breakthrough. A new Goldman Sachs report predicts smokeless nicotine products will surpass tobacco during consumption by 2025 and close to revenue and profits by 2035.
This shift is not the result of government policies. It's happening because consumers are making better choices. However, federal regulators seem to be determined to get in the way.
Nicotine may be addictive, but it does not cause cancer, heart disease, or emphysema. The perpetrator is burning.
The data could not be clarified. Millions of smokers have abandoned cigarettes with risky products such as vaping devices, nicotine pouches and heated cigarettes. Tobacco sales are falling sharply. It ranges from 12.9 billion packs in 2016 to 2.7 billion packs projected by 2035.
This trend should give public health agencies a reason to support them. Instead, the Food and Drug Administration is limping policies that don't make it difficult for adult smokers to switch to safer alternatives. The FDA's obstruction risks slowing down one of the most promising developments in decades to reduce smoking-related deaths.
Winning Free Market
Despite the flood of misinformation, the market has been successful where decades of public health campaigns have failed. It makes cigarettes outdated. Given the choice, consumers are dumping smoke for a safer alternative to supply nicotine without the fatal byproduct of burning. This is more than just progress. It's a groundbreaking victory to reduce harm.
The free market deserves credit for this shift. While government smoking ban efforts have leaned heavily towards punitive tactics such as higher taxes, grotesque warning labels and complete bans, a true reduction in smoking has come to where low-risk nicotine products are legal and accessible. In the US, this transformation is unfolding despite them, not for regulators.
At the heart of the issue is the FDA's pre-market tobacco application process. The PMTA system, designed to review new nicotine products, has become a bureaucratic bottleneck. It is opaque, glacial and unfairly strict. result? A legal market filled with uncertainty and an illegal market that thrives instead.
Today, more than 60% of e-vapor sales come from illegal and unregulated products. That's not because consumers like them. This is because the FDA has made it nearly impossible for legitimate companies to approve reduced risk products and place them on shelves. The agency created a regulatory vacuum – and the black market filled it.
Feedback
The dysfunction does not stop with vaping. Heated tobacco products and nicotine pouches – both are widely recognized overseas. Meanwhile, traditional tobacco is widely available and remains profitable. If public health is truly the FDA's goal, it does not quickly track low-risk alternatives and supports the very product that is most harmful.
However, FDA's foot spurts have real results. More Americans will continue to become obsessed with cigarettes for longer than they do other ways. The data is as follows: Alternative nicotine products help people stop smoking. Blocking legal access to them does not protect public health – it prolongs addiction and guarantees more smoking-related deaths. By halting the transition to safer products, the FDA has effectively locked in millions of people in a habit of killing about half of its users.
Regulatory inertia also puts stifling competition in the industry. Tobacco generates 66% of industry revenue and 70% of profit. The companies leading the accusations towards the future of those who don't sell cigarettes face the toughest regulatory headwinds. In fact, rather than accelerating the collapse, the government is protecting the tobacco market.
There is a better way. Federal regulators can defend this shift instead of thwarting it. The FDA must approve rapid approval of products that have significantly lower health risks than tobacco. Doing so will allow consumers to legally access to safer options while reducing the black market.
The people deserve the truth too. Nicotine may be addictive, but it does not cause cancer, heart disease, or emphysema. The perpetrator is burning. And the longer the confusion continues, the more smokers the FDA will leave behind.
Results or optics?
Federal regulators should begin helping businesses that are halting protections for the tobacco industry and keeping the United States away from flammable tobacco. It means giving independent vampire makers and harmful innovators a chance to fight rather than tightening the grip on big cigarettes through the capture of regulations.
Regulations should reduce the appeal of tobacco. Risk forecasting rules prioritize public health by tweaking smokers to low-risk products, not driving them to the black market or returning them to Marlboro.
The latest data from Goldman Sachs shows that the market is doing what public health campaigns can never do. If regulators get out of the way, or even better, big cigarette breakdowns can be even faster.
The cigarette is almost dying. The FDA can help fill them or continue to elicit final acts. The question is whether public health officials care more about optics or outcomes. The market is already selected. It's time for the government to catch up.
